announcement today about FDA clearance for use in diabetic ulcers ect.
thinking to myself
aroa still a biological product and Novosorb synthetic.
but why hasnt PNV commented or made any specific moves to market Novosorb in this space.
Aroa value the TAM for it as 1b+ in US alone.
does anyone know of any case studies or comments from management Around use to novosorb in chronic wounds with healing compromised by disease (diabetes)
cheers
- Forums
- ASX - By Stock
- PNV
- Aroa Discussion
Aroa Discussion
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.34 |
Change
0.065(2.86%) |
Mkt cap ! $1.615B |
Open | High | Low | Value | Volume |
$2.33 | $2.38 | $2.29 | $1.803M | 771.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 10532 | $2.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.34 | 16180 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 25503 | 2.320 |
19 | 35747 | 2.310 |
16 | 59038 | 2.300 |
10 | 131037 | 2.290 |
5 | 13634 | 2.280 |
Price($) | Vol. | No. |
---|---|---|
2.330 | 12203 | 23 |
2.340 | 39003 | 19 |
2.350 | 57705 | 17 |
2.360 | 32068 | 13 |
2.370 | 77225 | 13 |
Last trade - 12.01pm 26/06/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |